Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Nuclear Instruments & Methods in Physics Research. Section A, Accelerators, Spectrometers, Detectors and Associated Equipment|November 11, 2020
Evaluation of a high resolution silicon PET insert moduleMilan Grkovski, Karol Brzezinski, Vladimir Cindro, et al.Radiology and Oncology|July 30, 2020
[18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumabDamijan Valentinuzzi, Martina Vrankar, Nina Boc, et al.Physics in Medicine and Biology|December 11, 2024
Longitudinal interpretability of deep learning based breast cancer risk predictionZan Klanecek, Yao-Kuan Wang, Tobias Wagner, et al.Physics in Medicine and Biology|April 7, 2025
Sensitivity of a deep-learning-based breast cancer risk prediction modelZan Klanecek, Yao-Kuan Wang, Tobias Wagner, et al.Physics in Medicine and Biology|February 6, 2025
Impact of pectoral muscle removal on deep-learning-based breast cancer risk predictionZan Klanecek, Yao-Kuan Wang, Tobias Wagner, et al.Physics in Medicine and Biology|May 3, 2007
Performance evaluation of a very high resolution small animal PET imager using silicon scatter detectorsSang-June Park, W Leslie Rogers, Sam Huh, et al.Physics in Medicine and Biology|May 3, 2023
Uncertainty estimation for deep learning-based pectoral muscle segmentation via Monte Carlo dropoutZan Klanecek, Tobias Wagner, Yao-Kuan Wang, et al.Nuclear Instruments & Methods in Physics Research. Section A, Accelerators, Spectrometers, Detectors and Associated Equipment|December 18, 2007
A prototype of very high resolution small animal PET scanner using silicon pad detectorsSang-June Park, W Leslie Rogers, Sam Huh, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
Improving the Somatostatin Receptor Status Assessment for Personalized and Precise Management of Neuroendocrine Neoplasms with the Use of a 99mTc-Radiolabeled Somatostatin Receptor Antagonist: The Final Results of the ERA PerMed TECANT Clinical TrialAlicja Hubalewska-Dydejczyk, Clemens Decristoforo, Renata Mikolajczak, et al.Ecancermedicalscience|April 28, 2023
Challenges and opportunities for implementing hypofractionated radiotherapy in Africa: lessons from the HypoAfrica clinical trialElizabeth Olatunji, William Swanson, Saloni Patel, et al.Pageof 3